CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

s-licarbazepine

Small moleculeexperimental

Clinical trial activity

9 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
5
Phase 3
5
Phase 4
1

Earliest trial started Oct 1, 2004 (NCT00107926)

Timeline

2000s

  1. Jan 1, 2004

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2006

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

NC(=O)N1c2ccccc2CC(O)c2ccccc21
Mol. weight
254.29 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Racemic Mixture
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 10,11-dihydro-10-hydroxy-5h-dibenz(b,f)azepine-5-carboxamide
  • 10,11-mhd
  • 10-hydroxy-carbamazepine
  • 10-hydroxy-carbamazepine
  • licarbazepine
  • licarbazepine
  • licarbazepine
  • licarbazepine
  • s-licarbazepine
  • s-licarbazepine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00424671Phase 1Nov 1, 2006Novartis
NCT02281591Phase 1Jun 1, 2006Bial
NCT00426036Phase 1Jun 1, 2006Novartis
NCT00228059Phase 3Jan 1, 2005Novartis
NCT00238485Phase 3Jan 1, 2005Novartis
NCT00139594Phase 4Dec 1, 2004Novartis
NCT00107939Phase 3Nov 1, 2004Novartis
NCT00099229Phase 3Nov 1, 2004Novartis
NCT00107926Phase 3Oct 1, 2004Novartis
Showing 9 of 9 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
NovartisFor profit8832004
BialFor profit1112006
2 organizations
Page 1 / 1